ICH GCP has been revised — but what does it really mean for sponsor oversight?
Watch our recent webinar to gain a clear understanding of ICH GCP E6(R3) and its implications for sponsor responsibilities.
The speaker, Sanne Buhl, Chief Quality Officer (CQO) at LINK Medical, has extensive experience in clinical quality and regulatory compliance. She explains why early adoption of risk-proportionate oversight is critical—and how sponsors can strengthen accountability, especially through partnerships with CROs.
Want to learn more? Then you will benefit from the insights in our recently published white paper.
